These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 6371301)

  • 1. [Effects of insulin in myocardial protection].
    Mochizuki S; Ishikawa S; Masuda I; Saito N; Abe M
    Nihon Rinsho; 1983 Dec; 41(12):2787-94. PubMed ID: 6371301
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of streptozotocin diabetes and insulin treatment on myocardial sodium pump and contractility of the rat heart.
    Ku DD; Sellers BM
    J Pharmacol Exp Ther; 1982 Aug; 222(2):395-400. PubMed ID: 7047716
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucose-insulin-potassium solution improves left ventricular energetics in chronic ovine diabetes.
    Ramanathan T; Morita S; Huang Y; Shirota K; Nishimura T; Zheng X; Hunyor SN
    Ann Thorac Surg; 2004 Apr; 77(4):1408-14. PubMed ID: 15063275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of vanadate on in vivo myocardial reactivity to norepinephrine in diabetic rats.
    Paulson DJ; Kopp SJ; Tow JP; Peace DG
    J Pharmacol Exp Ther; 1987 Feb; 240(2):529-34. PubMed ID: 3543300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cross-clamp time, temperature, and cardioplegic agents on myocardial function after induced arrest.
    Kay HR; Levine FH; Fallon JT; Grötte GJ; Butchart EG; Rao S; McEnany MT; Austen WG; Buckley MJ
    J Thorac Cardiovasc Surg; 1978 Nov; 76(5):590-603. PubMed ID: 703364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enhanced myocardial protection by crystalloid cardioplegia at 4 degrees centigrade].
    Yano Y
    Nihon Kyobu Geka Gakkai Zasshi; 1983 Nov; 31(11):2027-36. PubMed ID: 6672122
    [No Abstract]   [Full Text] [Related]  

  • 7. The insulin-like properties of vanadium: a curiosity or a perspective for the treatment of diabetes?
    Brichard SM; Lederer J; Henquin JC
    Diabete Metab; 1991; 17(5):435-40. PubMed ID: 1752343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early abnormalities in myocardial cell function in experimental diabetes.
    Gøtzsche O
    Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 2():1-21. PubMed ID: 3017048
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental study of the effects of ventricular fibrillation at 20 degrees C on myocardial preservation].
    Ogawa K
    Nihon Kyobu Geka Gakkai Zasshi; 1987 Mar; 35(3):353-61. PubMed ID: 3298464
    [No Abstract]   [Full Text] [Related]  

  • 10. Myocardial protection.
    Lolley DM; Ray JF; Meyers WO; Sautter RD
    J Thorac Cardiovasc Surg; 1979 Apr; 77(4):631-3. PubMed ID: 423599
    [No Abstract]   [Full Text] [Related]  

  • 11. Vanadium compounds as insulin mimics.
    Orvig C; Thompson KH; Battell M; McNeill JH
    Met Ions Biol Syst; 1995; 31():575-94. PubMed ID: 8564818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose substrate in myocardial protection.
    Salerno TA; Wasan SM; Charrette EJ
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):59-62. PubMed ID: 7350389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Protective effect of glucose-insulin-potassium solutions in myocardial damage caused by emetine].
    de Micheli A; Medrano GA; Villarreal A; Sodi-Pallares D
    Arch Inst Cardiol Mex; 1975; 45(4):469-86. PubMed ID: 1101837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of myocardial function with glucose, insulin and potassium.
    Dennis RC; Harlow C; Egdahl RH; Hechtman HB
    Surg Gynecol Obstet; 1980 Aug; 151(2):185-90. PubMed ID: 6773161
    [No Abstract]   [Full Text] [Related]  

  • 15. [Heart arrest with the use of Kirsch's solution and GIK for myocardial protection; comparative studies].
    Kato I; Kaihatsu H; Sugimoto T; Koide Y; Tajima K
    Nihon Kyobu Geka Gakkai Zasshi; 1979 Apr; 27(4):464-6. PubMed ID: 469308
    [No Abstract]   [Full Text] [Related]  

  • 16. Additive myocardial protection during ischemic arrest with propranolol and potassium cardioplegia.
    Lucas SK; Magee PG; Flaherty JT; Gott VL; Gardner TJ
    Surg Forum; 1979; 30():257-60. PubMed ID: 538613
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of chronic glipizide treatment on the NIDD heart.
    Schaffer SW; Warner BA; Wilson GL
    Horm Metab Res; 1993 Jul; 25(7):348-52. PubMed ID: 8406318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiac contractility in senile, insulin-dependent, diabetic patients. Changes that occur after the administration of glucose and insulin].
    Holgado Silva C; De La Vega Vázquez JM; Simón Morales E; Santis Scoccia C; Rodríguez Bernal A; Aznar Reig A
    Rev Clin Esp; 1979 Mar; 152(5):375-8. PubMed ID: 461882
    [No Abstract]   [Full Text] [Related]  

  • 19. [Myocardial protective effect and negative inotropic effect of verapamil in potassium cardioplegia].
    Suzuki Y
    Nihon Kyobu Geka Gakkai Zasshi; 1984 Jun; 32(6):903-12. PubMed ID: 6491404
    [No Abstract]   [Full Text] [Related]  

  • 20. Cold blood potassium cardioplegia. Effects of increasing concentrations of potassium.
    Jellinek M; Standeven JW; Menz LJ; Hahn JW; Barner HB
    J Thorac Cardiovasc Surg; 1981 Jul; 82(1):26-37. PubMed ID: 7242128
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.